In a trial of patients with T2DM and BMI 27 kg/m2 or more receiving semaglutide injection for weight management, retinal disorders were reported by 6.9% of patients treated with semaglutide 2.4 mg/week, 6.2% of patients treated with semaglutide 1 mg/week, and 4.2% of patients treated with placebo
Ontario Health Technology Assessment Series 2013;13:124
The official prescribing information does mention depression under the Postmarketing Experience listing
This is called allodynia, or central sensitization, and is a common finding in chronic migraine
Aliquoting reconstituted IGF-1 LR3 into single-use vials immediately after reconstitution allows frozen storage at 20C for 612 months with only one thaw event, extending usability far beyond the 28-day multi-dose limit
I can't blame them for wanting to believe the doctor over me because I'm not a doctor